Search results for "주주환원정책"
No articles found
Please try different categories or search terms
Most Viewed
1
Lee Chan-won appointed as the model for Dong-A Pharmaceutical's cold medicine Panpyrin
2Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
3Samsung Electronics, target price of 200,000 won appears.. equivalent to 10 million won before stock split
4Samsung Electronics, 20 trillion operating profit in Q4..elevated expectations easily met
5KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year
Picks for You
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Electronics, target price of 200,000 won appears.. equivalent to 10 million won before stock split
KOSPI Breaks 4500.. Rally for Three Consecutive Days in the New Year
Stock Market Receives the Spirit of Jeoktomah.. First Day Breaks 4300 for the First Time
Samba Signs 1.1 Trillion Won Pharmaceutical Production Contract with European Pharmaceutical Company.. Acquisition of Local Production Plant in the US
Youngpoong·MBK Partners "Korea Zinc, Choi Yoon-bum Takes on High Risks to Secure Management Rights"
Photos & Videos
Lee Chan-won appointed as the model for Dong-A Pharmaceutical's cold medicine Panpyrin
Samsung Biologics Surpasses Annual Revenue of 4.5 Trillion Won... Operating Profit of 2 Trillion
Samsung Electronics, target price of 200,000 won appears.. equivalent to 10 million won before stock split
Samsung Electronics, 20 trillion operating profit in Q4..elevated expectations easily met
powered by 